Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Haleon | LSE:HLN | London | Ordinary Share | GB00BMX86B70 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 8.00 | 2.09% | 389.90 | 390.20 | 390.40 | 391.20 | 383.70 | 384.20 | 16,491,159 | 16:35:05 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Offices-holdng Companies,nec | 11.23B | 1.44B | 0.1579 | 24.72 | 34.88B |
From Mar 2023 to Mar 2025
By Denny Jacob
Haleon voluntarily recalled two versions of cough medicine Robitussin due to a microbial contamination.
The personal healthcare products provider said the recall affects eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult at the consumer level.
Haleon said the use of the affected product in immunocompromised individuals could potentially result in severe or life-threatening adverse events such as fungemia or disseminated fungal infection. In non-immunocompromised consumers, the population most likely to use the product, life-threatening infections aren't likely to occur, it added.
Haleon said to date it hasn't received reports of adverse events related to the recall.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
January 24, 2024 10:43 ET (15:43 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
1 Year Haleon Chart |
1 Month Haleon Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
